The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $17.74

Today's change+0.01 +0.06%
Updated August 18 4:00 PM EDT. Delayed by at least 15 minutes.
 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $17.74

Today's change+0.01 +0.06%
Updated August 18 4:00 PM EDT. Delayed by at least 15 minutes.

Ehealth Inc up slightly

Ehealth Inc closed up just (U.S.)$0.01 Friday to (U.S.)$17.74. Over the last five days, shares have gained 1.20% and 66.57% year to date. Shares have outperformed the S&P 500 by 41.24% during the last year.

Key company metrics

  • Open(U.S.) $17.56
  • Previous close(U.S.) $17.73
  • High(U.S.) $17.87
  • Low(U.S.) $17.52
  • Bid / Ask-- / --
  • YTD % change+66.57%
  • Volume190,931
  • Average volume (10-day)106,725
  • Average volume (1-month)142,987
  • Average volume (3-month)200,769
  • 52-week range(U.S.) $6.38 to (U.S.) $19.53
  • Beta1.58
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.36
Updated August 18 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-3.44%

Ehealth Inc has a net profit margin of -3.44%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.54%Sector:FinancialsIndustry:Insurance - Multiline

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue28794432
Total other revenue--------
Total revenue28794432
Gross profit28774332
Total cost of revenue0200
Total operating expense45476139
Selling / general / administrative45456039
Research & development--------
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)0--00
Other operating expenses, total--------
Operating income-1732-17-7
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-1732-17-7
Income after tax-1733-17-6
Income tax, total0-20-1
Net income-1733-17-6
Total adjustments to net income--------
Net income before extra. items-1733-17-6
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1733-17-6
Inc. avail. to common incl. extra. items-1733-17-6
Diluted net income-1733-17-6
Dilution adjustment--------
Diluted weighted average shares18191818
Diluted EPS excluding extraordinary itemsvalue per share-0.931.80-0.91-0.31
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.931.80-0.91-0.32